CNSY Cerenome, Inc.
P/E
--
Forward P/E
-0.70422536
Price/Sales
3.1600866
Beta
1.471
Div Yield
0.0%
Market Cap
--
Company Analysis
Latest News
🔴 Cerenome is trading 8.91% down in after-hours trading after reporting a $9.0 million Q2 net loss
Cerenome is trading 8.91% down at $3.35 in after-hours trading after releasing second-quarter results on August 14, 2026. - Q2 net loss was $9.0 million, or...
🟢 Cerenome is trading 6% up after agreement adds 27.3 million covered lives
Cerenome is trading at $3.92, up 5.95%, on August 13, 2026, after announcing an in-network agreement with Health Care Service Corporation. - The agreement...
🟢 Cerenome is trading 6% up in pre-market after in-network agreement expands CNSide access
Cerenome is trading 6.10% up in pre-market at $3.93 after announcing an in-network agreement with Health Care Service Corporation on August 13, 2026. - The...
Cerenome, Inc. Q2 2026 Earnings Preview: What Analysts Expect on August 13, 2026
Consensus estimates for Cerenome, Inc. project a Q2 2026 loss of $0.96 per share on revenue of $1.11 million, with the micro-cap stock trading at $3.84 against...